Trial · NCT02107859
Results by group37
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 37
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren | Any TEAEs | 61 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren | Mild AEs | 4 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren | Moderate AEs | 26 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren | Severe AEs | 30 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren | Life-threatening AEs | 0 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren | Fatal AEs | 1 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren | AEs unrelated to ataluren | 35 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren | AEs unlikely related to ataluren | 12 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren | AEs possible related to ataluren | 13 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren | AEs probable related to ataluren | 1 | Participants | |
| Number of Participants With Treatment-Emergent Adverse Events (TEAEs) | Ataluren | Serious TEAEs | 36 | Participants | |
| Number of Participants With Clinically Significant Laboratory Abnormalities | Ataluren | 0 | Participants | ||
| Change From Baseline in Percent Predicted Forced Expiratory Volume in 1 Second (FEV1) at the End of Treatment (Week 192), as Assessed by Spirometry | Ataluren | Baseline | 56.203 | Standard Deviation 17.2964 | percentage of predicted FEV1 |
| Change From Baseline in Percent Predicted Forced Expiratory Volume in 1 Second (FEV1) at the End of Treatment (Week 192), as Assessed by Spirometry | Ataluren | Change at Week 192 | -1.214 | Standard Deviation 3.6384 | percentage of predicted FEV1 |
| Percentage of Participants With Pulmonary Exacerbation, As Assessed by Modified Fuchs Criteria | Ataluren | 68.3 | percentage of participants | ||
| Percentage of Participants With Pulmonary Exacerbation, As Assessed by Expanded Fuchs' Criteria | Ataluren | 68.3 | percentage of participants | ||
| Percentage of Participants With Pulmonary Exacerbation, As Assessed by Classic Fuchs' Criteria | Ataluren | 58.3 | percentage of participants | ||
| Change From Baseline in 12-Lead Electrocardiogram (ECG) Parameters at Final Visit (Week 196) | Ataluren | Baseline: RR duration | 828.17 | Standard Deviation 132.15 | miiliseconds |
| Change From Baseline in 12-Lead Electrocardiogram (ECG) Parameters at Final Visit (Week 196) | Ataluren | Change at Week 196: RR duration | -14.27 | Standard Deviation 115.62 | miiliseconds |
| Change From Baseline in 12-Lead Electrocardiogram (ECG) Parameters at Final Visit (Week 196) | Ataluren | Baseline: PR duration | 145.02 | Standard Deviation 19.29 | miiliseconds |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02107859/results